| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 3 |
| 1 | CAPECITABINE | 2 |
| 2 | ASPIRIN | 1 |
| 3 | ASPIRIN 325 MG | 1 |
| 4 | ASPIRIN 81 MG | 1 |
| 5 | CYCLOSPORINE | 1 |
| 6 | DOCETAXEL | 1 |
| 7 | DOCETAXEL ANHYDROUS | 1 |
| 8 | FLUOROURACIL | 1 |
| 9 | FLUOROURACIL CREAM, 0.5% | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 1 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 2 | RAMUCIRUMAB | 1 | 0.0002 |
| 3 | OXALIPLATIN | 3 | 0.0000 |
| 4 | CAPECITABINE | 2 | 0.0000 |
| 5 | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 0.0000 |
| 6 | DOCETAXEL | 1 | 0.0000 |
| 7 | DOCETAXEL ANHYDROUS | 1 | 0.0000 |
| 8 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 9 | FLUOROURACIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |